Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
Pavel PituleMiroslava CedikovaOndrej DaumJan VojtisekOndrej VycitalPetr HošekVladislav TreskaOndrej HesMilena KralickovaVaclav LiskaPublished in: BioMed research international (2014)
Effect of cancer stem cell markers on prognosis of colorectal cancer can vary depending on pathological classification of tumor, and we have shown that CD133, generally considered to be a negative marker, can bear also clinically positive prognostic information in group of patients with colorectal liver metastases.
Keyphrases
- cancer stem cells
- liver metastases
- metastatic colorectal cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- nk cells
- machine learning
- peritoneal dialysis
- prognostic factors
- healthcare
- deep learning
- patient reported outcomes
- health information
- real time pcr
- drug induced
- quantum dots
- sensitive detection